VALOR Act

HR4393 — DIGNIDAD (Dignity) Act of 2025

This bill would create a comprehensive immigration and border-security overhaul that layers new physical barriers and surveillance with big changes to employer verification, asylum processing, and legal-status pathways. It bundles construction and funding, a rethought E‑Verify system, expedited asylum at humanitarian campuses, and new conditional and Dignity status routes for long‑term residents. - Would expand humanitarian processing and asylum rules for migrants. It would establish at least three southern border humanitarian campuses for screening, medical checks, legal orientation, and an expedited asylum track with a 72‑hour arrival rest and a 15‑day initial screening goal. - Would change worksite verification and employer rules. It would replace the current system with a new Employment Eligibility Verification System, phase mandatory employer use by size over 6–24 months, allow secondary checks and a limited good‑faith defense, and raise penalties and debarment authority for violations. - Would invest in ports, infrastructure, and backlog tools and create a new trust fund. It would authorize $2.0 billion annually for ports in FY2026–2030, create an Immigration Infrastructure and Debt Reduction Fund, and permit premium processing deposits including a $20,000 premium option to address visa backlogs. Would authorize substantial new appropriations and fee deposits, including $2.0 billion annually for FY2026–2030, increasing federal outlays.

HR3077 — Agriculture Resilience Act of 2025

This bill centers on achieving net-zero agricultural greenhouse gas emissions by 2040 through a broad federal strategy of on-farm changes, research, and large-scale funding. It sets interim goals including a 50% cut in agricultural emissions by 2030 and targets for soil carbon, cover crops, agroforestry, grazing, renewable energy, and food-waste reduction while directing new research hubs and breed development funding to support the transition. - Farmers and ranchers: Expands conservation programs, adds premium discounts for defined climate-smart practices in crop insurance starting with the 2026 reinsurance year, and funds on-farm projects like a $1.5 billion Alternative Manure Management Program for FY2026–2030. These changes tie payments and contracts to multi-year conservation and soil-health plans. - Underserved and Tribal producers: Prioritizes technical assistance and grants, requires targeted outreach, and reserves TA and grant set-asides to help beginning, veteran, socially disadvantaged, limited-resource, and Tribal producers access programs and markets. - Food systems and consumers: Creates mandatory standards and verification for animal-raising label claims within two years, standardizes voluntary date labels with a two-year rulemaking timeline, and funds composting and food-waste grants including $100 million annually for State projects. This bill would increase federal spending by authorizing multi-year mandatory and discretionary funding lines, including sizable CCC additions and program appropriations.

HR7481 — Department of Homeland Security Appropriations Act, 2026

DHS funding with strict oversight. This bill would set FY2026 funding levels across the Department of Homeland Security and attach detailed reporting, transfer limits, and program rules to many accounts.

HR4206 — CONNECT for Health Act of 2025

Expands Medicare telehealth access by removing geographic limits and ending an in-person requirement for telemental health. It would also change payment rules for clinics and require more oversight, training, and data reporting. - Medicare beneficiaries would be able to receive telehealth across geographies beginning October 1, 2025. Telemental health would no longer require a six-month in-person visit and tribal and Native Hawaiian facilities would be exempt from originating-site rules starting January 1, 2026. - Federally Qualified Health Centers and Rural Health Clinics would be paid for telehealth under outpatient or prospective payment methods and telehealth costs as distant-site care would count as allowable PPS costs. The HHS Secretary could waive limits on which practitioner types may furnish telehealth starting October 1, 2025 with annual public comment and a three-year reassessment requirement. - The bill would strengthen program integrity funding for telehealth, require CMS to post quarterly telehealth data, and add telehealth to quality-measure reviews within 180 days. It also mandates a beneficiary engagement study and a Government Accountability Office report on hospice recertification within three years.

HR2548 — Sanctioning Russia Act of 2025

Automatic, recurring sanctions on the Russian government and its affiliates. This bill would create a multi-layered sanctions regime that forces mandatory measures within 15 days of a covered determination and requires reassessment every 90 days. - U.S. financial institutions and investors: Banks, brokers, and U.S. investment funds would be barred from processing transfers to the Russian Federation, buying Russian sovereign debt, or making monetary investments in entities owned or controlled by the Russian government. Many prohibitions would take effect within 15 days of a covered determination and recur every 90 days. - Energy, trade, and commodities: The bill would ban U.S. exports of energy to Russia, bar investments in the Russian energy sector, and prohibit imports of uranium sourced from Russia or Rosatom. It would also raise duties on imports from Russia to not less than 500 percent and allow similar duties on third countries trading in Russian-origin energy commodities. - Individuals, exchanges, and payment networks: High‑ranking Russian officials, oligarchs, and sector actors would face property blocks and visa ineligibility under the International Emergency Economic Powers Act (IEEPA). The SEC would be directed to bar listing or trading of Russian‑affiliated issuers and global financial messaging providers could be sanctioned for continuing service to designated banks.

HR1262 — Mikaela Naylon Give Kids a Chance Act

Speeds and strengthens pediatric cancer drug development. It expands which cancer products companies must study in children, reshapes organ transplant network governance and fees, and adds new FDA international and transparency steps. - Children with cancer and researchers: Requires pediatric studies that produce clinically meaningful data on dosing, safety, and early effectiveness and widens the kinds of drug combinations studied. It also sets aside $25 million for pediatric drug studies in each of fiscal years 2026, 2027, and 2028. - Transplant patients and transplant network members: Changes Organ Procurement and Transplantation Network governance and financing by allowing quarterly registration fees, requiring those fees fund OPTN operations, improving electronic health record integration, and calling for a GAO review within two years. - FDA partners and drug makers: Creates an Abraham Accords Office to boost regulatory coordination and technical assistance abroad, and forces more transparency during generic (ANDA) reviews about whether generics are qualitatively and quantitatively the same as listed drugs. It also raises the Medicare Improvement Fund amount from $1.4 billion to $2.6 billion. Increases federal outlays by roughly $1.3 billion, driven by a $1.2 billion boost to the Medicare Improvement Fund and $75 million for pediatric studies, adding to federal spending.